BIOMARKERS OF CARDIAC FIBROSIS IN ARTERIAL HYPERTENSION-Reference-Cited by-同舟云学术

BIOMARKERS OF CARDIAC FIBROSIS IN ARTERIAL HYPERTENSION

Published:2020 Issue:4 Volume:47 Page:
ISSN:2072-9367
Container-title:Modern medical technologies
language:uk
Short-container-title:

Author:

Dotsenko N. Ya.¹,Gerasimenko L. V.¹,Boev S. S.¹,Shekhunova I. A.¹,Molodan A. V.¹,Malinovskaya A. Ya.¹,Yatsenko O. V.¹

Affiliation:

1. State Institution «Zaporizhzhia Medical Academy of post-graduate education Ministry of Health of Ukraine»

Abstract

Abstract The article presents a review of the literature on the role of myocardial fibrosis in the development of myocardial remodeling in patients with arterial hypertension. Information about the state of the structure and function of the extracellular matrix in health and disease is generalized. The characteristics of myocardial fibrosis biomarkers detection in the circulating blood are reflected. Keywords: arterial hypertension, myocardial fibrosis, extracellular matrix, collagen, biomarkers.

Publisher

Zaporizhia Medical Academy of Post-Graduate Education

Subject

General Medicine

Reference66 articles.

1. Marchal S, Arnoud WJ van’t Hof, Hollander M The new European guideline on cardiovascular disease prevention; how to make progress in general practice? Eur. J. Gen. Pract. 2018; 24 (1): 57–59. DOI: 10.1080/13814788.2017.1401063.

2. Lim SS, Vos T, Flaxman AD et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380 (9859): 2224–260. DOI: https://doi.org/10.1016/S0140- 6736(12)61766-8.

3. Keteepe-Arachi T, Sharma S Cardiac Fibrosis in Hypertension. J. Hypertens. Manag.2017; 3 (1): 3: 023. DOI:10.23937/2474-3690/1510023.

4. Kalyuzhin VV, Teplyakov AT, Solovtsov MA et al. Left ventricular remodeling: one or more scenarios? Bjulleten' sibirskoj mediciny. 2016; 15 (4): 120–139. DOI: 10.20538/1682-0363- 2016-4-120–139.

5. Frangogiannis NG. Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol. Aspects. Med. 2019; 65: 70–99. DOI: 10.1016/j.mam.2018.07.001.